Logo image of SURG.CA

SURGE COPPER CORP (SURG.CA) Stock Fundamental Analysis

Canada - TSX-V:SURG - CA86881M1041 - Common Stock

0.255 CAD
-0.01 (-1.92%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, SURG scores 2 out of 10 in our fundamental rating. SURG was compared to 818 industry peers in the Metals & Mining industry. SURG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SURG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SURG had negative earnings in the past year.
SURG had a negative operating cash flow in the past year.
SURG had negative earnings in each of the past 5 years.
SURG had a negative operating cash flow in each of the past 5 years.
SURG.CA Yearly Net Income VS EBIT VS OCF VS FCFSURG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2M -4M -6M -8M

1.2 Ratios

SURG has a better Return On Assets (-3.85%) than 74.82% of its industry peers.
SURG has a better Return On Equity (-4.18%) than 77.26% of its industry peers.
Industry RankSector Rank
ROA -3.85%
ROE -4.18%
ROIC N/A
ROA(3y)-3.72%
ROA(5y)-7.73%
ROE(3y)-4.12%
ROE(5y)-8.46%
ROIC(3y)N/A
ROIC(5y)N/A
SURG.CA Yearly ROA, ROE, ROICSURG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15

1.3 Margins

SURG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SURG.CA Yearly Profit, Operating, Gross MarginsSURG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for SURG has been increased compared to 1 year ago.
The number of shares outstanding for SURG has been increased compared to 5 years ago.
Compared to 1 year ago, SURG has an improved debt to assets ratio.
SURG.CA Yearly Shares OutstandingSURG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SURG.CA Yearly Total Debt VS Total AssetsSURG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 10.74 indicates that SURG is not in any danger for bankruptcy at the moment.
The Altman-Z score of SURG (10.74) is better than 69.19% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that SURG is not too dependend on debt financing.
SURG has a Debt to Equity ratio (0.00) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.74
ROIC/WACCN/A
WACCN/A
SURG.CA Yearly LT Debt VS Equity VS FCFSURG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

A Current Ratio of 4.84 indicates that SURG has no problem at all paying its short term obligations.
SURG has a Current ratio of 4.84. This is in the better half of the industry: SURG outperforms 73.11% of its industry peers.
A Quick Ratio of 4.84 indicates that SURG has no problem at all paying its short term obligations.
The Quick ratio of SURG (4.84) is better than 73.59% of its industry peers.
Industry RankSector Rank
Current Ratio 4.84
Quick Ratio 4.84
SURG.CA Yearly Current Assets VS Current LiabilitesSURG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.73% over the past year.
EPS 1Y (TTM)15.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SURG.CA Yearly EPS VS EstimatesSURG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 -0.02 -0.04 -0.06

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SURG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SURG.CA Price Earnings VS Forward Price EarningsSURG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SURG.CA Per share dataSURG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SURG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SURGE COPPER CORP

TSX-V:SURG (10/6/2025, 7:00:00 PM)

0.255

-0.01 (-1.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-19 2025-08-19
Earnings (Next)11-12 2025-11-12
Inst Owners2.71%
Inst Owner ChangeN/A
Ins Owners10.44%
Ins Owner ChangeN/A
Market Cap88.08M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.69
P/tB 1.69
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.85%
ROE -4.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.72%
ROA(5y)-7.73%
ROE(3y)-4.12%
ROE(5y)-8.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10566.9%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.84
Quick Ratio 4.84
Altman-Z 10.74
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)12368.4%
Cap/Depr(5y)12338.5%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.87%
OCF growth 3YN/A
OCF growth 5YN/A